Cargando…
Current perspectives on biosimilars
In this work, an overview of the biosimilars market, pipeline and industry targets is discussed. Biosimilars typically have a shorter timeline for approval (8 years) compared to 12 years for innovator drugs and the development cost can be 10–20% of the innovator drug. The biosimilar pipeline is revi...
Autores principales: | Agbogbo, Frank K., Ecker, Dawn M., Farrand, Allison, Han, Kevin, Khoury, Antoine, Martin, Aaron, McCool, Jesse, Rasche, Ulrike, Rau, Tiffany D., Schmidt, David, Sha, Ma, Treuheit, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791907/ https://www.ncbi.nlm.nih.gov/pubmed/31317293 http://dx.doi.org/10.1007/s10295-019-02216-z |
Ejemplares similares
-
Upstream development of Escherichia coli fermentation process with PhoA promoter using design of experiments (DoE)
por: Agbogbo, Frank K., et al.
Publicado: (2020) -
Optimized invertase expression and secretion cassette for improving Yarrowia lipolytica growth on sucrose for industrial applications
por: Lazar, Zbigniew, et al.
Publicado: (2013) -
New lager yeast strains generated by interspecific hybridization
por: Krogerus, Kristoffer, et al.
Publicado: (2015) -
An efficient method for the immobilization of inulinase using new types of polymers containing epoxy groups
por: Trytek, Mariusz, et al.
Publicado: (2015) -
Bioprocess monitoring: minimizing sample matrix effects for total protein quantification with bicinchoninic acid assay
por: Reichelt, Wieland N., et al.
Publicado: (2016)